TY - JOUR
T1 - Patient preferences for diabetes management among people with type 2 diabetes in Denmark - a discrete choice experiment
AU - Bøgelund, Mette
AU - Vilsbøll, Tina
AU - Faber, Jens
AU - Henriksen, Jan Erik
AU - Gjesing, Rasmus Prior
AU - Lammert, Morten
PY - 2011/11
Y1 - 2011/11
N2 - Objectives: To study patient preferences for diabetes-treatment related attributes among people with type 2 diabetes. Research design and methods: Participants were recruited from three diabetes out-patient clinics and two general practitioner surgeries. Data were collected electronically and results were analysed using a standard statistical model designed for choice sets (conditional logit). Six characteristics relating to treatment of diabetes were examined: glycated haemoglobin level (HbA1c), weight (gain or loss), hypoglycaemic events, need for injections, transient nausea and need for blood glucose testing. Results: Two hundred and seventy participants with type 2 diabetes (178 males; 92 females) were included. Patients placed the most value on losing weight and were willing to pay the most to lose 6kg of weight. Loss of 3kg of weight was the next highly valued, followed by dropping one percentage point in HbA1c level. Avoidance of nausea and a reduction in hypoglycaemic events from two per month to none was also highly valued. Patients were willing to accept one injection per day if they, for instance, simultaneously lost 1.4kg. A limitation of the study is that the survey was web-based and response rates for such surveys can be extremely variable. Conclusion: Patients with type 2 diabetes in Denmark were willing to pay for the health benefits associated with improved diabetes treatment, the most important of these being weight loss or avoidance of weight gain, and reduction of HbA1c and of hypoglycaemic events.
AB - Objectives: To study patient preferences for diabetes-treatment related attributes among people with type 2 diabetes. Research design and methods: Participants were recruited from three diabetes out-patient clinics and two general practitioner surgeries. Data were collected electronically and results were analysed using a standard statistical model designed for choice sets (conditional logit). Six characteristics relating to treatment of diabetes were examined: glycated haemoglobin level (HbA1c), weight (gain or loss), hypoglycaemic events, need for injections, transient nausea and need for blood glucose testing. Results: Two hundred and seventy participants with type 2 diabetes (178 males; 92 females) were included. Patients placed the most value on losing weight and were willing to pay the most to lose 6kg of weight. Loss of 3kg of weight was the next highly valued, followed by dropping one percentage point in HbA1c level. Avoidance of nausea and a reduction in hypoglycaemic events from two per month to none was also highly valued. Patients were willing to accept one injection per day if they, for instance, simultaneously lost 1.4kg. A limitation of the study is that the survey was web-based and response rates for such surveys can be extremely variable. Conclusion: Patients with type 2 diabetes in Denmark were willing to pay for the health benefits associated with improved diabetes treatment, the most important of these being weight loss or avoidance of weight gain, and reduction of HbA1c and of hypoglycaemic events.
U2 - 10.1185/03007995.2011.625404
DO - 10.1185/03007995.2011.625404
M3 - Journal article
SN - 0141-9951
VL - 27
SP - 2175
EP - 2183
JO - Current Medical Research and Opinion, Supplement
JF - Current Medical Research and Opinion, Supplement
IS - 11
ER -
